Business Description
C-Rad AB
ISIN : SE0002016352
Share Class Description:
FRA:24C: Shs -B-Compare
Compare
Traded in other countries / regions
CRAD B.Sweden0R44.UK24C.Germany IPO Date
2021-02-11Description
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa and the rest from Americas and Asia Pacific region.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.52 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.14 | |||||
| Interest Coverage | 13.74 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 6.44 | |||||
| Beneish M-Score | -2.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.6 | |||||
| 3-Year EBITDA Growth Rate | 26.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.4 | |||||
| 3-Year FCF Growth Rate | 11.6 | |||||
| 3-Year Book Growth Rate | 10.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 43.57 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.34 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.45 | |||||
| 9-Day RSI | 35 | |||||
| 14-Day RSI | 35.13 | |||||
| 6-1 Month Momentum % | -0.32 | |||||
| 12-1 Month Momentum % | -1.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.14 | |||||
| Quick Ratio | 2.69 | |||||
| Cash Ratio | 0.93 | |||||
| Days Inventory | 145.72 | |||||
| Days Sales Outstanding | 113.21 | |||||
| Days Payable | 76.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.33 | |||||
| Operating Margin % | 13.77 | |||||
| Net Margin % | 11.92 | |||||
| FCF Margin % | 9.89 | |||||
| ROE % | 20.16 | |||||
| ROA % | 13.59 | |||||
| ROIC % | 21.71 | |||||
| 3-Year ROIIC % | 22.45 | |||||
| ROC (Joel Greenblatt) % | 76.04 | |||||
| ROCE % | 22.7 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.79 | |||||
| Forward PE Ratio | 12.88 | |||||
| PE Ratio without NRI | 16.79 | |||||
| Shiller PE Ratio | 782.44 | |||||
| Price-to-Owner-Earnings | 77.58 | |||||
| PEG Ratio | 0.38 | |||||
| PS Ratio | 1.98 | |||||
| PB Ratio | 3.09 | |||||
| Price-to-Tangible-Book | 3.35 | |||||
| Price-to-Free-Cash-Flow | 20.22 | |||||
| Price-to-Operating-Cash-Flow | 20.22 | |||||
| EV-to-EBIT | 12.85 | |||||
| EV-to-Forward-EBIT | 9.34 | |||||
| EV-to-EBITDA | 11.31 | |||||
| EV-to-Forward-EBITDA | 8.45 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 1.54 | |||||
| EV-to-FCF | 17.87 | |||||
| Price-to-Projected-FCF | 1.97 | |||||
| Price-to-Median-PS-Value | 0.37 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.66 | |||||
| Price-to-Graham-Number | 1.57 | |||||
| Price-to-Net-Current-Asset-Value | 3.61 | |||||
| Earnings Yield (Greenblatt) % | 7.79 | |||||
| FCF Yield % | 4.96 | |||||
| Forward Rate of Return (Yacktman) % | 21.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
C-Rad AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 43.081 | ||
| EPS (TTM) (€) | 0.151 | ||
| Beta | 1.22 | ||
| Volatility % | 45.98 | ||
| 14-Day RSI | 35.13 | ||
| 14-Day ATR (€) | 0.120711 | ||
| 20-Day SMA (€) | 2.707 | ||
| 12-1 Month Momentum % | -1.1 | ||
| 52-Week Range (€) | 2.325 - 4.24 | ||
| Shares Outstanding (Mil) | 33.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
C-Rad AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
C-Rad AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
C-Rad AB Frequently Asked Questions
What is C-Rad AB(FRA:24C)'s stock price today?
The current price of FRA:24C is €2.35. The 52 week high of FRA:24C is €4.24 and 52 week low is €2.33.
When is next earnings date of C-Rad AB(FRA:24C)?
The next earnings date of C-Rad AB(FRA:24C) is 2025-02-07.
Does C-Rad AB(FRA:24C) pay dividends? If so, how much?
C-Rad AB(FRA:24C) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers